Recent research on cytokines associated with anti-N-methyl-D-aspartate receptor encephalitis.
10.7499/j.issn.1008-8830.2211125
- Author:
Ya-Xin ZHENG
1
;
Li JIANG
1
Author Information
1. Department of Neurology, Children's Hospital of Chongqing Medical University/National Clinical Research Center for Child Health and Disorders/Ministry of Education Key Laboratory of Child Development and Disorders/Chongqing Key Laboratory of Pediatrics, Chongqing 400014, China.
- Publication Type:Journal Article
- Keywords:
Anti-N-methyl-D-aspartate receptor encephalitis;
Biomarker;
Child;
Cytokine
- MeSH:
Humans;
Cytokines;
Anti-N-Methyl-D-Aspartate Receptor Encephalitis/therapy*;
Biomarkers
- From:
Chinese Journal of Contemporary Pediatrics
2023;25(3):321-327
- CountryChina
- Language:Chinese
-
Abstract:
Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is an autoimmune inflammatory disease of the central nervous system, and little is known about its immune mechanism at present. There is a lack of disease-related biomarkers in cerebrospinal fluid except anti-NMDAR antibody, which leads to delayed diagnosis and treatment in some patients. Therefore, there has been an increasing number of studies on related cytokines in recent years to assess whether they can be used as new biomarkers for evaluating disease conditions and assisting diagnosis and treatment. Current studies have shown that some cytokines may be associated with the progression of anti-NMDAR encephalitis, and this article reviews the research advances in such cytokines associated with anti-NMDAR encephalitis.
